两个个体中具有纯合PTPN11基因变异的努南综合征家族的临床变异性。

IF 1.5 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM Journal of Clinical Research in Pediatric Endocrinology Pub Date : 2024-03-11 Epub Date: 2023-10-17 DOI:10.4274/jcrpe.galenos.2023.2023-5-16
Ruken Yıldırım, Edip Unal, Şervan Özalkak, Akçahan Akalın, Ayça Aykut, Nevzat Yılmaz
{"title":"两个个体中具有纯合PTPN11基因变异的努南综合征家族的临床变异性。","authors":"Ruken Yıldırım, Edip Unal, Şervan Özalkak, Akçahan Akalın, Ayça Aykut, Nevzat Yılmaz","doi":"10.4274/jcrpe.galenos.2023.2023-5-16","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Noonan syndrome (NS) is characterized by dysmorphic facial features, short stature, congenital heart defects, and varying levels of developmental delays. It is a genetic, multisystem disorder with autosomal dominant inheritance and is the most common of the RASopathies. In approximately 50% of patients, NS is caused by variants in the Protein Tyrosine Phosphatase Non-Receptor Type 11 (<i>PTPN11</i>) gene. The aim of this study was to evaluate two patients with a previously reported <i>PTPN11</i> homozygous variant for the first time and seven other kindred members carrying the same heterozygous variant in terms of clinical, biochemical, genetic, and response to treatment.</p><p><strong>Methods: </strong>Nine patients diagnosed with NS due to the same variants in the <i>PTPN11</i> gene were included in the study.</p><p><strong>Results: </strong>The median (range) age at diagnosis was 11.5 (6.8-13.9) years and the mean follow-up duration was 4.7 (1-7.6) years. In eight patients (88.9%), short stature was present. The height standard deviation score of the patients on admission was -3.24±1.15. In six of the patients, growth hormone treatment was initiated. Cardiovascular or bleeding disorders were not detected in any of the patients. Three (33.3%) had hearing loss, two (22.2%) had ocular findings and one (11.1%) had a horseshoe kidney. The mean psychomotor development performance score was 84.03±17.09 and the verbal score was 82.88±9.42. Genetic analysis revealed a variant in the <i>PTPN11</i> gene [c.772G>A; (p.Glu258Lys)] that had been previously described and was detected in all patients. Two patients were homozygous for this variant and short stature was more severe in these two.</p><p><strong>Conclusion: </strong>A previously described in <i>PTPN11</i> affected nine members of the same kindred, two with homozygous inheritance and the remainder being heterozygous. To the best of our knowledge, these are the first homozygous <i>PTPN11</i> case reports published, coming from two related consanguineous families.</p>","PeriodicalId":48805,"journal":{"name":"Journal of Clinical Research in Pediatric Endocrinology","volume":" ","pages":"76-83"},"PeriodicalIF":1.5000,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10938517/pdf/","citationCount":"0","resultStr":"{\"title\":\"Clinical Variability in a Family with Noonan Syndrome with a Homozygous <i>PTPN11</i> Gene Variant in Two Individuals\",\"authors\":\"Ruken Yıldırım, Edip Unal, Şervan Özalkak, Akçahan Akalın, Ayça Aykut, Nevzat Yılmaz\",\"doi\":\"10.4274/jcrpe.galenos.2023.2023-5-16\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Noonan syndrome (NS) is characterized by dysmorphic facial features, short stature, congenital heart defects, and varying levels of developmental delays. It is a genetic, multisystem disorder with autosomal dominant inheritance and is the most common of the RASopathies. In approximately 50% of patients, NS is caused by variants in the Protein Tyrosine Phosphatase Non-Receptor Type 11 (<i>PTPN11</i>) gene. The aim of this study was to evaluate two patients with a previously reported <i>PTPN11</i> homozygous variant for the first time and seven other kindred members carrying the same heterozygous variant in terms of clinical, biochemical, genetic, and response to treatment.</p><p><strong>Methods: </strong>Nine patients diagnosed with NS due to the same variants in the <i>PTPN11</i> gene were included in the study.</p><p><strong>Results: </strong>The median (range) age at diagnosis was 11.5 (6.8-13.9) years and the mean follow-up duration was 4.7 (1-7.6) years. In eight patients (88.9%), short stature was present. The height standard deviation score of the patients on admission was -3.24±1.15. In six of the patients, growth hormone treatment was initiated. Cardiovascular or bleeding disorders were not detected in any of the patients. Three (33.3%) had hearing loss, two (22.2%) had ocular findings and one (11.1%) had a horseshoe kidney. The mean psychomotor development performance score was 84.03±17.09 and the verbal score was 82.88±9.42. Genetic analysis revealed a variant in the <i>PTPN11</i> gene [c.772G>A; (p.Glu258Lys)] that had been previously described and was detected in all patients. Two patients were homozygous for this variant and short stature was more severe in these two.</p><p><strong>Conclusion: </strong>A previously described in <i>PTPN11</i> affected nine members of the same kindred, two with homozygous inheritance and the remainder being heterozygous. To the best of our knowledge, these are the first homozygous <i>PTPN11</i> case reports published, coming from two related consanguineous families.</p>\",\"PeriodicalId\":48805,\"journal\":{\"name\":\"Journal of Clinical Research in Pediatric Endocrinology\",\"volume\":\" \",\"pages\":\"76-83\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-03-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10938517/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Research in Pediatric Endocrinology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4274/jcrpe.galenos.2023.2023-5-16\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/10/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Research in Pediatric Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4274/jcrpe.galenos.2023.2023-5-16","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/10/17 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:努南综合征(NS)以面部畸形、身材矮小、先天性心脏缺陷和不同程度的发育迟缓为特征。它是一种常染色体显性遗传的遗传性多系统疾病,是最常见的RA疾病。在大约50%的患者中,NS是由蛋白酪氨酸磷酸酶非受体11型(PTPN11)的变体引起的。本研究旨在评估两名先前报道的PTPN11变体首次处于纯合状态的患者和其他七名携带相同杂合变体的家庭成员的临床、生化、遗传和治疗反应。材料和方法:本研究包括9名因PTPN11基因相同变异而被诊断为努南综合征(NS)的患者。结果:患者诊断时的年龄为11.5岁(范围:6.8-13.9),平均随访时间为4.7年(范围:1-7.6)。8名患者(88.9%)出现身材矮小。入院时患者的身高SDS为-3.24±1.15。其中6名患者开始接受生长激素治疗。在任何患者中均未发现心血管或出血性疾病。三名(33.3%)患者有听力损失,两名(22.2%)有眼部表现,一名(11.1%)有马蹄形肾。患者的心理运动发展表现得分为84.03±17.09,言语得分为82.88±9.42。遗传分析的结果是,在所有患者中都检测到PTPN11基因[c.772G>a;(p.Glu258Lys)]中先前在文献中描述的变体。两名患者是该变体的纯合子,这些患者身材矮小更为严重。结论:在PTPN11基因中检测到一种以前在文献中描述过的变体,该变体在两名患者中是纯合的。据我们所知,这是文献中第一例纯合PTPN11病例报告,来自两个相关的血亲家庭。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Clinical Variability in a Family with Noonan Syndrome with a Homozygous PTPN11 Gene Variant in Two Individuals

Objective: Noonan syndrome (NS) is characterized by dysmorphic facial features, short stature, congenital heart defects, and varying levels of developmental delays. It is a genetic, multisystem disorder with autosomal dominant inheritance and is the most common of the RASopathies. In approximately 50% of patients, NS is caused by variants in the Protein Tyrosine Phosphatase Non-Receptor Type 11 (PTPN11) gene. The aim of this study was to evaluate two patients with a previously reported PTPN11 homozygous variant for the first time and seven other kindred members carrying the same heterozygous variant in terms of clinical, biochemical, genetic, and response to treatment.

Methods: Nine patients diagnosed with NS due to the same variants in the PTPN11 gene were included in the study.

Results: The median (range) age at diagnosis was 11.5 (6.8-13.9) years and the mean follow-up duration was 4.7 (1-7.6) years. In eight patients (88.9%), short stature was present. The height standard deviation score of the patients on admission was -3.24±1.15. In six of the patients, growth hormone treatment was initiated. Cardiovascular or bleeding disorders were not detected in any of the patients. Three (33.3%) had hearing loss, two (22.2%) had ocular findings and one (11.1%) had a horseshoe kidney. The mean psychomotor development performance score was 84.03±17.09 and the verbal score was 82.88±9.42. Genetic analysis revealed a variant in the PTPN11 gene [c.772G>A; (p.Glu258Lys)] that had been previously described and was detected in all patients. Two patients were homozygous for this variant and short stature was more severe in these two.

Conclusion: A previously described in PTPN11 affected nine members of the same kindred, two with homozygous inheritance and the remainder being heterozygous. To the best of our knowledge, these are the first homozygous PTPN11 case reports published, coming from two related consanguineous families.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Clinical Research in Pediatric Endocrinology
Journal of Clinical Research in Pediatric Endocrinology ENDOCRINOLOGY & METABOLISM-PEDIATRICS
CiteScore
3.60
自引率
5.30%
发文量
73
审稿时长
20 weeks
期刊介绍: The Journal of Clinical Research in Pediatric Endocrinology (JCRPE) publishes original research articles, reviews, short communications, letters, case reports and other special features related to the field of pediatric endocrinology. JCRPE is published in English by the Turkish Pediatric Endocrinology and Diabetes Society quarterly (March, June, September, December). The target audience is physicians, researchers and other healthcare professionals in all areas of pediatric endocrinology.
期刊最新文献
Pediatric Type 1 Diabetes Care in Indonesia: A Review of Current Challenges and Practice. Evaluation of Arrhythmia Risk in Children with Type 1 Diabetes Mellitus. Is Automated Insulin Delivery System Therapy Safe and Effectıve in Children Under 7 Years Old? Normative Values for Thyroid Volume and Tracheal Index in Healthy Turkish Newborns in an Iodine Sufficient Region. Germ Cell Dysfunction is Universal in Male Patients with β-Thalassemia Following Hematopoietic Stem Cell Transplantation During Childhood and Adolescence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1